Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | RGT-018 |
Synonyms | |
Therapy Description |
RGT-018 selectively inhibits SOS1, potentially resulting in decreased tumor cell proliferation and reduced tumor growth (PMID: 39087485). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
RGT-018 | RGT 018|RGT018 | SOS1 Inhibitor 16 | RGT-018 selectively inhibits SOS1, potentially resulting in decreased tumor cell proliferation and reduced tumor growth (PMID: 39087485). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
BRAF V600E | melanoma | no benefit | RGT-018 | Preclinical - Cell culture | Actionable | In a preclinical study, RGT-018 did not inhibit proliferation of melanoma cells harboring BRAF V600E in 3D culture (PMID: 39087485). | 39087485 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|